Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW
Diabetic Medicine · 2026
DOI: 10.1111/dme.70155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Vivian Yejee Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales, Newtown, New South Wales, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes, Gestational. Die Arbeit nennt 28 Literaturangaben. Gefördert von: University of New South Wales.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Gestational diabetes mellitus (GDM) is a well‐established independent risk factor for type 2 diabetes mellitus (T2DM) and cardiovascular disease. As risks emerge within the first decade following childbirth, early intervention is required. However, competing postpartum priorities and limited time inhibit many women from prioritising their post‐GDM health. Therefore, the study aimed to: (1) Measure dysglycaemia prevalence and identify predictors among Australian women with recent GDM and (2) understand women's views regarding their risk of future T2DM and approach to potential preventive strategies, including post‐GDM preventive pharmacotherapy.
Methods
Cross‐sectional study of women with recent (within 5 years) GDM, including an online questionnaire and oral glucose tolerance test completion by participants.
Results
Participants ( n = 505) had a mean age of 37.3 ± 4.9 years, body mass index (BMI) of 27.5 ± 6.4 kg/m 2 and were 2.9 ± 1.4 years postpartum. Of the 248 (49.1%) participants completing an oral glucose tolerance test, 4% had T2DM and 11% had pre‐diabetes. Each 1 kg/m 2 increase in BMI was associated with 10% greater odds of dysglycaemia ( p = 0.03). On a 10‐point scale (10 = highest), the median self‐reported 5‐year risk of developing T2DM was 5 [IQR: 3–7], and concern about developing T2DM was 7 [5–9]. Women strongly agreed (10 [8–10]) that preventing or delaying T2DM onset was important. Women reported being very likely to adopt lifestyle changes (4 [4–5] out of 5), and somewhat likely to take medication for T2DM prevention (3 [1–4] out of 5).
Conclusion
Women consider preventing or delaying the onset of diabetes very important. Hence, studies evaluating adjunct therapies, such as pharmacotherapy, are needed to reduce their long‐term risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Institute for Global Health, University of New South Wales, Newtown, New South Wales, Australia.
- Newbridge, New South Wales, Australia.
- Royal Hospital for Women and Prince of Wales Hospital, Randwick, New South Wales, Australia.
- Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia.
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia.
- Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
ORCID-Profile: Vivian Yejee Lee
Förderung
- University of New South Wales
Zitieren
APA
Lee, V. Y., Donges, K., Beech, A., Makris, A., Arnott, C., Patel, A., & Henry, A. (2026). Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW. Diabetic Medicine. https://doi.org/10.1111/dme.70155
Vancouver
Lee VY, Donges K, Beech A, Makris A, Arnott C, Patel A, et al. Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW. Diabetic Medicine. 2026. doi:10.1111/dme.70155
BibTeX
@article{Lee2026,
author = {Lee, Vivian Yejee and Donges, Katherine and Beech, Amanda and Makris, Angela and Arnott, Clare and Patel, Anushka and Henry, Amanda},
title = {Type 2 diabetes after gestational diabetes, a cross‐sectional study— DIVINE ‐ NSW},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70155}
}
EUVIMED